In English | En español

National Cancer Institute

at the National Institutes of Health

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Clinical Trials Search Results

Page Options

Email This Document

Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat

Popular Resources

Help Using the NCI Clinical Trials Search Form
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-25 of 33 for your search:

Drug:  vitamin E
Find trials that include:  Any drugs shown
Trial Status:  Closed

Hide Search Criteria

Show Search Criteria

Help with Results

Select All on Page Sort by: Show Results per Page

Phase III Randomized Study of Sucralfate Suspension vs Topical Vitamin E for the Treatment of Chemotherapy-Induced Mucositis

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1Z93, NCI-P94-0059

Phase III Randomized, Double-Blind, Placebo-Controlled Study of VIT-E for the Control of Hot Flushes in Menopausal Women with Prior Breast Cancer

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-959253, NCI-P95-0065

Phase III Randomized Study of the Effect of a Diet Low in Fat and High in Soy, Fruits, Vegetables, Green Tea, Vitamin E, and Fiber on PSA Levels in Patients With Prostate Cancer (Summary Last Modified 04/2002)

Phase: Phase III
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-98014, NCI-G98-1445, NCT00003367

Phase III Randomized Study of Donepezil and Vitamin E in the Prevention of Cognitive Dysfunction Following Cancer Treatment That Included Prophylactic Cranial Irradiation in Patients With Small Cell Lung Cancer

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N99C5, NCI-P00-0169, NCT00006349

S0000 Selenium and Vitamin E in Preventing Prostate Cancer

Phase: Phase III
Type: Prevention
Status: Closed
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000068277, U10CA032102, S0000, CAN-NCIC-S0000, CALGB-S0000, ECOG-S0000, NCCAM, NCI-P00-0172, SWOG-S0000, NCT00006392

Phase III Randomized, Placebo-Controlled Study of Beta-Carotene and Vitamin E in the Prevention of Lung Cancer (Summary Last Modified 10/88)

Phase: Phase III
Type: Prevention
Status: Closed
Age: 50 to 69
Sponsor:
Protocol IDs: DCPC-CPSB-10005

Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)

Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 69
Sponsor:
Protocol IDs: DCPC-CPSB-11204

Phase III Randomized, Double-Blind Study of Multiple Vitamins at the Recommended Daily Allowance (RDA) vs Multiple Vitamins at the RDA plus High-Dose Vitamins A, B6, C, and E in Patients with Transitional Cell Carcinoma of the Bladder (Summary Last Modified 06/91)

Phase: Phase III
Type: Supportive care
Status: Closed
Age: any age
Sponsor:
Protocol IDs: WVU-11715, NCI-V91-0025

Phase III Randomized Study of Adjuvant Isotretinoin, Interferon alfa, and Vitamin E in Patients With Stage III or IV Squamous Cell Carcinoma of the Head and Neck

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-1301, E1301, NCT00054561

10.

Phase III Randomized Study of Vitamin E in Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients Undergoing Curative Neurotoxic Chemotherapy for Cancer

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N05C3, NCT00363129

11.

Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 0808, NCT00809458

12.

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Phase: Phase III
Type: Prevention
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: PRP1, CAN-NCIC-PRP1, CDR0000310096, NCT00064194

13.

Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer

Phase: Phase III
Type: Prevention
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: 69, R01HL043851, HL043851, CA047988, NCT00000479

14.

Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)

Phase: Phase III
Type: Natural history/Epidemiology
Status: Closed
Age: 60 to 90
Sponsor: NCI, Other
Protocol IDs: IA0033, 5R01AG019241, SWOG-S0000A, S0000A, NCT00780689, NCT00040378

15.

Phase I/II Study of Topotecan, Fludarabine, Cytarabine, and Filgrastim (T-FLAG) Induction Therapy Followed by Maintenance Therapy of Either Peripheral Blood Stem Cells or Isotretinoin in Patients With Poor Prognosis Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Recurrent or Refractory Acute Lymphocytic Leukemia

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 19 to 90
Sponsor: Other
Protocol IDs: AUH-MCP-70612-01, AUH-MCP-70612-02P, NCI-V98-1485, NCT00003619

16.

Phase II Randomized Study of Isotretinoin With or Without Vitamin E for the Chemoprevention of Lung Cancer

Phase: Phase II
Type: Prevention, Supportive care
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: UCHSC-92382, NCI-V94-0506, NCT00002586

17.

Phase II Study of Adjuvant Biologic Therapy for Preventing Recurrence and Second Primary Tumors in Patients with Stage III or IV Squamous Cell Cancer of the Head and Neck

Phase: Phase II
Type: Prevention, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-95015, NCI-H98-0011

18.

Phase II Randomized Study of Vitamin E and Pentoxifylline in Patients With Lymphedema After Radiotherapy for Breast Cancer

Phase: Phase II
Type: Supportive care
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: RM-1597, EU-20050, NCT00022204

19.

Phase II Study of Isotretinoin (Accutane) plus rIFN-A in Adults with Mycosis Fungoides

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8816

20.

Safety of Antioxidants During GYN Cancer Care

Phase: Phase II
Type: Treatment
Status: Closed
Age: No age specified
Sponsor: Other
Protocol IDs: 10006, NCT00284427

21.

Trental & Vitamin E for Radiation-Induced Fibrosis

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 20 and over
Sponsor: Other
Protocol IDs: 200211003, NCT00583700

22.

Phase I Randomized Study of Selenium With or Without Vitamin E for the Prevention of Lung Cancer in Smokers (Summary Last Modified 11/2000)

Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: KUMC-7159-97, NCI-P00-0152

23.

Phase IB Toxicity Reduction Trial of TRA with VIT-E

Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: MCP-9199, NCI-T91-0173H, T91-0173

24.

Phase I Study of Vitamin E in Healthy Adults (Summary Last Modified 09/92)

Phase: Phase I
Type: Prevention
Status: Completed
Age: 25 to 69
Sponsor:
Protocol IDs: MSU-3821, NCI-P92-0021

25.

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 120802, P30CA072720, CDR0000639070, CINJ-120802, NCT00895115

Select All on Page

Help with Results

We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat

NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map

Other Versions of this Site: Mobile | Español

Follow Us:

Twitter
YouTube
Facebook
RSS

NIH…Turning Discovery Into Health^®